Gobert Gosse Stéphanie, Bourgin Caroline, Liu Wang Qing, Garbay Christiane, Mouchiroud Guy
Centre de Génétique Moléculaire et Cellulaire, UMR CNRS 5534, Bâtiment Gregor Mendel, Université Lyon1, 69622 Villeurbanne , France.
Cell Signal. 2005 Nov;17(11):1352-62. doi: 10.1016/j.cellsig.2005.02.002. Epub 2005 Mar 23.
Macrophage colony-stimulating factor (M-CSF) is a physiological regulator of monocyte-macrophage lineage. Ectopic expression of the M-CSF receptor (M-CSFR, or Fms) in murine myeloid cell line FDC-P1 (FD/Fms cells) results in M-CSF-dependent macrophage differentiation. Previously, we observed that M-CSF induces two temporally distinct phases of mitogen-activated protein kinase (MAPK) phosphorylation. Here we show that levels of phosphorylated MAPK kinase MEK1 follow the same kinetics as MAPK phosphorylation, characterized by an early and transient phase (the first 30 min of M-CSF stimulation) and a late and persistent phase from 4 h of stimulation. The MEK inhibitor U0126 strongly inhibited both phases of MAPK phosphorylation as well as FD/Fms cell differentiation, indicating that MAPK may relay M-CSF differentiation signaling downstream of M-CSFR. Treatment of FD/Fms cells with U0126 during the first hour of M-CSF stimulation reversibly blocked the early phase of MAPK phosphorylation but did not affect differentiation. In contrast, U0126 still inhibited FD/Fms cell differentiation when its addition was delayed by 24 h. This demonstrated that late and persistent MEK activity is specifically required for macrophage differentiation to occur. Furthermore, disrupting Grb2-Sos complexes with a specific blocking peptide did not prevent FD/Fms cells differentiation in response to M-CSF, nor did it abolish MAPK phosphorylation. The role of phosphatidylinositol 3-kinase (PI 3-kinase), another potential regulator of the MAPK pathway, was examined using the specific inhibitor LY294002. This compound could not impede FD/Fms cell commitment to macrophage differentiation and did not significantly affect MAPK phosphorylation in response to M-CSF. Therefore, M-CSF differentiation signaling in myeloid progenitor cells is mediated through persistent MEK activity but it is not strictly dependent upon Grb2-Sos interaction or PI 3-kinase activity.
巨噬细胞集落刺激因子(M-CSF)是单核细胞-巨噬细胞谱系的生理调节因子。M-CSF受体(M-CSFR,即Fms)在小鼠骨髓细胞系FDC-P1(FD/Fms细胞)中的异位表达导致依赖M-CSF的巨噬细胞分化。此前,我们观察到M-CSF诱导丝裂原活化蛋白激酶(MAPK)磷酸化出现两个时间上不同的阶段。在此我们表明,磷酸化的MAPK激酶MEK1的水平与MAPK磷酸化遵循相同的动力学,其特征是早期短暂阶段(M-CSF刺激的前30分钟)和刺激4小时后的晚期持续阶段。MEK抑制剂U0126强烈抑制MAPK磷酸化的两个阶段以及FD/Fms细胞分化,表明MAPK可能在M-CSFR下游传递M-CSF分化信号。在M-CSF刺激的第一小时用U0126处理FD/Fms细胞可逆地阻断了MAPK磷酸化的早期阶段,但不影响分化。相反,当U0126添加延迟24小时时,它仍然抑制FD/Fms细胞分化。这表明巨噬细胞分化发生特别需要晚期持续的MEK活性。此外,用特异性阻断肽破坏Grb2-Sos复合物并不能阻止FD/Fms细胞对M-CSF的分化反应,也不能消除MAPK磷酸化。使用特异性抑制剂LY294002研究了磷脂酰肌醇3激酶(PI 3激酶)这一MAPK途径的另一个潜在调节因子的作用。该化合物不能阻碍FD/Fms细胞向巨噬细胞分化,并且对M-CSF刺激的MAPK磷酸化没有显著影响。因此,骨髓祖细胞中的M-CSF分化信号是通过持续的MEK活性介导的,但它并不严格依赖于Grb2-Sos相互作用或PI 3激酶活性。